Abstract
Dental implants have emerged as one of the most consistent and predictable treatments in the oral surgery field. However, the placement of the implant is sometimes associated with bacterial infection leading to its loss. In this work, we intend to solve this problem through the development of a biomaterial for implant coatings based on 45S5 Bioglass® modified with different amounts of niobium pentoxide (Nb2O5). The structural feature of the glasses, assessed by XRD and FTIR, did not change in spite of Nb2O5 incorporation. The Raman spectra reveal the Nb2O5 incorporation related to the appearance of NbO4 and NbO6 structural units. Since the electrical characteristics of these biomaterials influence their osseointegration ability, AC and DC electrical conductivity were studied by impedance spectroscopy, in the frequency range of 102–106 Hz and temperature range of 200–400 K. The cytotoxicity of glasses was evaluated using the osteosarcoma Saos-2 cells line. The in vitro bioactivity studies and the antibacterial tests against Gram-positive and Gram-negative bacteria revealed that the samples loaded with 2 mol% Nb2O5 had the highest bioactivity and greatest antibacterial effect. Overall, the results showed that the modified 45S5 bioactive glasses can be used as an antibacterial coating material for implants, with high bioactivity, being also non-cytotoxic to mammalian cells.
Funding Information
  • National Funds through FCT—Portuguese Foundation for Science and Technology (LISBOA-01-0247-FEDER-039985/POCI-01-0247-FEDER-039985, LA/P/0037/2020, UIDP/50025/2020, UIDB/50025/2020, UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020, SFRH/BD/148233/2019, UI/DB/151287/202)
  • Associate Laboratory Institute of Nanostructures, Nanomodelling and Nanofabrication—i3N (LISBOA-01-0247-FEDER-039985/POCI-01-0247-FEDER-039985, LA/P/0037/2020, UIDP/50025/2020, UIDB/50025/2020, UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020, SFRH/BD/148233/2019, UI/DB/151287/202)
  • Research Unit on Applied Molecular Biosciences—UCIBIO (LISBOA-01-0247-FEDER-039985/POCI-01-0247-FEDER-039985, LA/P/0037/2020, UIDP/50025/2020, UIDB/50025/2020, UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020, SFRH/BD/148233/2019, UI/DB/151287/202)
  • Associate Laboratory Institute for Health and Bioeconomy—i4HB (LISBOA-01-0247-FEDER-039985/POCI-01-0247-FEDER-039985, LA/P/0037/2020, UIDP/50025/2020, UIDB/50025/2020, UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020, SFRH/BD/148233/2019, UI/DB/151287/202)
  • FCT—Portuguese Foundation for Science and Technology (LISBOA-01-0247-FEDER-039985/POCI-01-0247-FEDER-039985, LA/P/0037/2020, UIDP/50025/2020, UIDB/50025/2020, UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020, SFRH/BD/148233/2019, UI/DB/151287/202)
  • FCT—Fundação para a Ciência e a Tecnologia (LISBOA-01-0247-FEDER-039985/POCI-01-0247-FEDER-039985, LA/P/0037/2020, UIDP/50025/2020, UIDB/50025/2020, UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020, SFRH/BD/148233/2019, UI/DB/151287/202)

This publication has 88 references indexed in Scilit: